Ultra-low dose rituximab as add-on therapy in anti-MDA5-positive patients with polymyositis /dermatomyositis associated ILD - Concepedia

Concepedia

Publication | Closed Access

Ultra-low dose rituximab as add-on therapy in anti-MDA5-positive patients with polymyositis /dermatomyositis associated ILD

32

Citations

25

References

2020

Year

Mengmeng Mao, Shu Xia, Bingpeng Guo, Weiping Qian, Ze-xuan Zheng, Xiaomin Peng, Rongchang Chen, Qun Luo, Qian Han

Respiratory Medicine

RheumatologyAutoimmune DiseaseImmunologyUltra-low Dose RituximabImmunotherapyMedicineAnti-mda5-positive PatientsAdd-on Therapy

References

	Year	Citations

Page 1